logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Petros Christopoulos

thoraxklinik at heidelberg university hospital
H指数:40
被引数:5,289

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Feasibility of consolidative immunotherapy and outcomes of chemoradiation for limited-stage small-cell lung cancer in the real world

巩固性免疫治疗联合化疗放疗对局限期小细胞肺癌的可行性与真实世界疗效

Therapeutic Advances in Medical Oncology
IF4.2
2026-10-240
PRE
Shuo Shi; Teresa Romero Cruz; Florian Stritzke; Romina Maria Rösch; Marlene Luther-Lütkehus; Anna Hofmann; Benedikt Niedermaier; Michael Allgäuer; Farastuk Bozorgmehr; Rajiv Shah; Jonas Kuon; Thomas Held; Fabian Weykamp; Albrecht Stenzinger; Florian Eichhorn; Laura Klotz; Michael Thomas; Gerald Schmid-Bindert; Petros Christopoulos
Durvalumab Consolidation After Definitive Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Cohort Analysis from the German Prospective, Observational CRISP Registry (AIO-TRK-0315)

不可切除III期非小细胞肺癌患者行根治性放化疗后的度鲁特单抗巩固治疗：来自德国前瞻性、观察性CRISP登记研究（AIO-TRK-0315）的真实世界队列分析

Cancers
IF4.4
2026-08-170
OAAI
Martin Stuschke; Michael Thomas; Andreas Gröschel; Martin Sebastian; Martin Reck; Petra Hoffknecht; Christian Grah; Lisa Spring; Martina Jänicke; Carolin Lennartz; Paula Ludwig; Annika Groth; Parvis Sadjadian; Petros Christopoulos; Daniel Christian Christoph; Frank Griesinger; Bernward Passlick
Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group

既往与同期糖皮质激素和抗生素治疗对免疫治疗疗效的差异化影响——德国AIO研究组RAMONA、INTEGA、OPTIM、ELDORANDO、FORCE、TITAN-RCC和TITAN-TCC试验的合并分析

British Journal of Cancer
IF6.8
2026-05-190
OAAI
Isabella C. Wiest; Lena Dreikhausen; Ralph Keller; Marcos Marin-Galiano; Laurence Albiges; Johannes Meran; Katharina Leucht; Stefan Rieken; Emilio Esteban; Friedemann Zengerling; Joseph Tintelnot; Marc-Oliver Grimm; Farastuk Bozorgmehr; Petros Christopoulos; Alexander Stein; Mascha Binder; Nicolai Härtel; Konrad Klinghammer; Viktor Grünwald; Michael Pogorzelski; Matthias P. Ebert
Correction: Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples

更正：对1233例FFPE实体瘤样本进行诊断性全转录组测序

British Journal of Cancer
IF6.8
2026-03-020
OAAI
Markus Ball; Susanne Beck; Darius Wlochowitz; Tina Fuchs; Katja Lorenz; Christiane Zgorzelski; Alejandro Pallares Robles; Michael Allgäuer; Anna-Lena Volckmar; Hannah Goldschmid; Iordanis Ourailidis; Regine Brandt; Petros Christopoulos; Michael Thomas; Huriye Seker-Cin; Annette Fink; Fabian Schnecko; Olaf Neumann; Michael Menzel; Martina Kirchner; Thoas Fioretos; Peter Schirmacher; Solange Peters; Jan Budczies; Albrecht Stenzinger; Daniel Kazdal
Bridging the gap: A systematic approach to integrating serum and plasma proteomic datasets for biomarker studies

弥合差距：一种整合血清和血浆蛋白质组学数据集用于生物标志物研究的系统性方法

Journal of Pharmaceutical and Biomedical Analysis
IF3.1
2026-02-010
OAAI
Lahav, Coren; Dahan, Nili; Harel, Michal; Elon, Yehonatan; Sela, Itamar; Geyer, Philipp E.; Schneider, Marc A.; Muley, Thomas; Bacchiocchi, Antonella; Marte, Jennifer; Floudas, Charalampos S.; Halaban, Ruth; Sznol, Mario; Christopoulos, Petros; Gulley, James L.
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples

在1233例FFPE实体瘤样本中进行的诊断性全转录组测序

British Journal of Cancer
IF6.8
2026-01-140
OAAI
Markus Ball; Susanne Beck; Darius Wlochowitz; Tina Fuchs; Katja Lorenz; Christiane Zgorzelski; Alejandro Pallares Robles; Michael Allgäuer; Anna-Lena Volckmar; Hannah Goldschmid; Iordanis Ourailidis; Regine Brandt; Petros Christopoulos; Michael Thomas; Huriye Seker-Cin; Annette Fink; Fabian Schnecko; Olaf Neuman; Michael Menzel; Martina Kirchner; Thoas Fioretos; Peter Schirmacher; Solange Peters; Jan Budczies; Albrecht Stenzinger; Daniel Kazdal
PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)

PET/CT引导下对转移性肺癌长期应答者的免疫检查点阻断管理及治疗后多模式分析——德国国家网络基因组医学肺癌项目（nNGM）

Annals of Oncology
IF65.4
2025-12-300
OAAI
N. Frost; M. Joosten; J. Franzen; M. Wiesweg; A. Rasokat; J. Kulhavy; J. Kollmeier; N. Reinmuth; C. Grohé; J. Roeper; A. Rittmeyer; S. Heinzen; M. Wermke; C. Wesseler; P. Christopoulos; D. Kauffmann-Guerrero; A. Althoff; A. Bleckmann; M. Collienne; E. Berezucki
Impact of Combined Additional Resections on the Surgical Outcomes of Robot-Assisted Resection of Thymic Epithelial Tumors

联合附加切除术对机器人辅助胸腺上皮肿瘤切除术手术结果的影响

Journal of Surgical Oncology
IF1.9
2025-12-010
OAAI
Niedermaier, Benedikt; Khan, Nabil; Eichhorn, Florian; Zehentmeier, Maria; Grosch, Heidrun; Griffo, Raffaella; Campisi, Alessio; Margineanu, Antonia; Allgauer, Michael; Christopoulos, Petros; Thomas, Michael; Winter, Hauke; Eichhorn, Martin E.
Real-World Characteristics, Treatment Patterns, and Outcomes in Advanced HER2 (ERBB2)-Mutant Non-Small Cell Lung Cancer: A Retrospective Study of Single Centers in France and Germany

真实世界特征、治疗模式及结局：HER2 (ERBB2)突变型晚期非小细胞肺癌的法国和德国单中心回顾性研究

Clinical Therapeutics
IF3.6
2025-11-010
OAAI
Petros Christopoulos; Christin Assmann; Lirong Zhang; Kyle Dunton; Ahmed Ali; Mehmet Berktas; Lisa Delmastro; Alessandria Strübing; Yan Xiong; Sarah Lay-Flurrie; Pooja Hindocha; Tarana Mehdikhanova; Nicolas Girard
First-line nivolumab plus ipilimumab in pleural mesothelioma: Efficacy and safety data from the real-world MesoNet study

一线纳武利尤单抗联合伊匹木单抗治疗恶性胸膜间皮瘤：来自真实世界MesoNet研究的疗效与安全性数据

Lung Cancer
IF4.4
2025-08-050
OAAI
Rajiv Shah; Eva L. Buchmeier; Hans-Georg Kopp; Daniel C. Christoph; Frank Griesinger; Martin Reck; Petra Hoffknecht; Jonas Kuon; Nikolaj Frost; Christian Grohé; Martin Faehling; Jingting Luan; Julia Roeper; Paolo Chesi; Miriam Blasi; Martin Kimmich; Till Olchers; Helge Bischoff; Laura V. Klotz; Inn Chung; Petros Christopoulos; Michael Thomas
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)

重新评估针对非小细胞肺癌的姑息性放疗联合PD-1阻断疗法：FORCE II期试验（AIO/YMO-TRK-0415）的结果

Clinical & Experimental Metastasis
IF3.2
2025-07-240
OAAI
Farastuk Bozorgmehr; Inn Chung; Jürgen R. Fischer; Marc Bischof; Akin Atmaca; Sophie Wetzel; Martin Faehling; Dirk Bottke; Martin Wermke; Esther G. C. Troost; Cornelia Kropf-Sanchen; Thomas Wiegel; Bernd Schmidt; Andrej Stupavsky; Walburga Engel-Riedel; Michaela Hammer-Hellmig; Niels Reinmuth; Farkhad Manapov; Christian Grohe; Robert Krempien; Christian Schumann; Florian Sterzing; Martin Reck; Florian Würschmidt; Jochen Fleckenstein; Alev Petroff; Sven Henschke; Rouven Behnisch; Jelena Cvetkovic; Lena Brückner; Constantin Schwab; Albrecht Stenzinger; Thorsten Götze; Christina Kopp; Helge Schröder; Jürgen Debus; Petros Christopoulos; Michael Thomas; Stefan Rieken
Treatment outcome of NSCLC patients with BRAFnon-V600E mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany

德国国家基因组医学网络（nNGM）肺癌项目中，BRAF非-V600E突变型非小细胞肺癌患者的治疗效果：一项回顾性、多中心分析

ESMO Open
IF8.3
2025-07-140
OAAI
C. Kropf-Sanchen; A. Rasokat; P. Christopoulos; C. Wenzel; T. Wehler; M. Rost; J. Kulhavy; N. Reinmuth; C. Schulz; M. Scheffler; J. Wolf; R. Büttner; S. Merkelbach-Bruse; M. Thomas; A. Stenzinger; M. Schütz; A. Bräuninger; M. Demes; H.-D. Hummel; N. Pfarr; N.T. Gaisa; J. Rawluk; E. Berezucki; K.T. Lutz; S. Galda; H. Jacobi; M. Collienne; M. Janning; T. Brummer; S. Loges
Treatment Sequences in BRAF-V600–Mutated NSCLC: First-Line Targeted Therapy Versus First-Line (Chemo-) Immunotherapy

BRAF-V600-Mutated NSCLC的治疗顺序: 一线靶向治疗与一线 (化疗) 免疫治疗

Journal of Thoracic Oncology
IF20.8
2025-05-080
OAAI
Marcel Wiesweg; Ali Alaffas; Anna Rasokat; Felix Carl Saalfeld; Maximilian Rost; Christin Assmann; Franziska Herster; Moritz Hilbrandt; Frank Griesinger; Anna Kron; Julia Roeper; Franziska Glanemann; Cornelia Kropf-Sanchen; Martin Reck; Jonas Kulhavy; Albrecht Stenzinger; Jürgen Wolf; Martin Sebastian; Martin Schuler; Martin Wermke; Nikolaj Frost; Hans-Georg Kopp; Petros Christopoulos; Matthias Scheffler
Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer

游离DNA的低覆盖度全基因组测序，用于预测和追踪晚期非小细胞肺癌的免疫治疗反应

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
IF12.8
2025-03-081
OA
Janke, Florian; Gasser, Mateo; Angeles, Arlou K.; Riediger, Anja L.; Goertz, Magdalena; Appenheimer, Louise; Laut, Astrid K.; Ogrodnik, Simon; Gerhardt, Sabrina; Stenzinger, Albrecht; Schneider, Marc A.; Thomas, Michael; Christopoulos, Petros; Sueltmann, Holger
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy

EGFR突变的非小细胞肺癌的小细胞转化: DLL3的表达和免疫检查点抑制剂或酪氨酸激酶抑制剂联合化疗的疗效

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-12-010
OAAI
Saalfeld, Felix Carl; Moeller, Johanna; Christopoulos, Petros; Wenzel, Carina; Rasokatf, Anna; Wangg, Xuejun Alice; Vathiotish, Ioannis; Koenigi, David; Illinij, Oliver; Grohe, Christian; Wiesweg, Marcel; Wesseler, Claas; Schubart, Christoph; Pelusi, Natalie; Rohde, Gernot; Overbeck, Tobias R.; Kirfel, Jutta; Alt, Juergen; Kauffmann-Guerrero, Diego; Griesingerv, Frank; Kulhavyw, Jonas; Allgaeuer, Michael; Klimovay, Anna; Schuetz, Maret; Aust, Daniela E.; Hochmairj, Maximilian J.; Rothschild, Sacha I.; Syrigos, Konstantinos N.; Veluswamy, Rajwanth; Michels, Sebastian; Stenzinger, Albrecht; Joehrens, Korinna; Wermke, Martin

研究方向

暂未获取到该数据
A
Albrecht Stenzinger
H 指数:79论文数:968被引数:2.9万
M
Michael Thomas
H 指数:74论文数:722被引数:3.2万
D
Daniel Kazdal
H 指数:31论文数:182被引数:3,224
F
Farastuk Bozorgmehr
H 指数:22论文数:117被引数:1,972
T
Thomas Muley
H 指数:64论文数:500被引数:1.8万
J
Jan Budczies
H 指数:65论文数:423被引数:2.4万
P
Peter Schirmacher
H 指数:108论文数:1,417被引数:6.2万
M
Martina Kirchner
H 指数:32论文数:148被引数:3,176
M
Michael Allgäuer
H 指数:40论文数:229被引数:6,355
H
H. Winter
H 指数:57论文数:793被引数:1.5万